Bruce Johnson
Pulmonary Disease · Virginia Beach, VANPI 1619076643
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 297 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,422 and has fallen 63.5% since, to $884 in 2021.
Across 297 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$898
- AstraZeneca$841
- Sunovion Pharmaceuticals Inc.$352
- Jazz Pharmaceuticals Inc.$288
- Mallinckrodt Enterprises LLC$237
- Boehringer Ingelheim$233
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 77 | $898 |
| AstraZeneca | 55 | $841 |
| Sunovion Pharmaceuticals Inc. | 20 | $352 |
| Jazz Pharmaceuticals Inc. | 12 | $288 |
| Mallinckrodt Enterprises LLC | 15 | $237 |
| Boehringer Ingelheim | 12 | $233 |
| Mallinckrodt Hospital Products Inc. | 11 | $201 |
| Advanced Respiratory, Inc | 10 | $163 |
| Actelion Pharmaceuticals US, Inc. | 7 | $160 |
| Genentech USA, Inc. | 9 | $156 |
| Insmed, Inc. | 12 | $143 |
| Novartis | 4 | $96 |
| Sanofi | 5 | $94 |
| Grifols USA, LLC | 4 | $84 |
| Resmed Corp | 5 | $82 |
| Regeneron Healthcare Solutions, Inc. | 5 | $82 |
| Mylan Specialty L.p. | 5 | $64 |
| Philips North America LLC | 3 | $60 |
| Pfizer | 4 | $56 |
| Harmony Biosciences LLC | 3 | $49 |
| Johnson & Johnson | 2 | $42 |
| Bayer | 3 | $38 |
| Gilead | 2 | $34 |
| Electromed, Inc. | 2 | $26 |
| Circassia Inc. | 2 | $25 |
| Pulmonx Corporation | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Nabriva Therapeutics, PLC | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$111
How this compares
$4,655 in reported general payments places this provider in the 60th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Virginia Beach
- Vasantha HathwarVirginia Beach$13K
- Steven NathanFalls Church$1.5M
- Omar MinaiHopewell$1.3M
- Rabih HalabiFalls Church$604K
- Eric LibreAnnandale$302K
- Sujoy GillRichmond$296K
- Imre NothCharlottesville$256K
- Carlos SilvaChesapeake$245K
- Vijay SubramaniamWilliamsburg$228K
- Ellen VolkerCharlottesville$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.